The economic impact of periprosthetic infections following total knee arthroplasty at a specialized tertiary-care center

Journal of Arthroplasty

Volumn 29, Issue 5, 2014, Pages 929-932

  Kapadia, Bhaveen H ^a   McElroy, Mark J ^a   Issa, Kimona ^a   Johnson, Aaron J ^a   Bozic, Kevin J ^b   Mont, Michael A ^a  

^a SINAI HOSPITAL OF BALTIMORE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Economic analysis; Healthcare costs; Periprosthetic infection; Surgical site infection; Total knee arthroplasty

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DATA BASE; ECONOMIC ASPECT; HEALTH CARE COST; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; LENGTH OF STAY; PERIPROSTHETIC JOINT INFECTION; SURGICAL INFECTION; TERTIARY HEALTH CARE; TOTAL KNEE REPLACEMENT;

ECONOMIC ANALYSIS; HEALTHCARE COSTS; PERIPROSTHETIC INFECTION; SURGICAL SITE INFECTION; TOTAL KNEE ARTHROPLASTY;

AMBULATORY CARE; ARTHROPLASTY, REPLACEMENT, KNEE; HOSPITAL COSTS; HUMANS; LENGTH OF STAY; PATIENT READMISSION; PROSTHESIS-RELATED INFECTIONS; SURGICAL WOUND INFECTION; TERTIARY CARE CENTERS; UNITED STATES;

EID: 84899103176     PISSN: 08835403     EISSN: 15328406     Source Type: Journal    
DOI: 10.1016/j.arth.2013.09.017     Document Type: Article

References (12)

1. Bozic K.J., Kurtz S.M., Lau E., et al. The epidemiology of revision total knee arthroplasty in the United States. Clin Orthop Relat Res 2010, 468(1):45.
2. Kurtz S.M., Lau E., Watson H., et al. Economic burden of periprosthetic joint infection in the United States. J Arthroplasty 2012, 27(8 Suppl):61.
3. Whitehouse J.D., Friedman N.D., Kirkland K.B., et al. The impact of surgical-site infections following orthopedic surgery at a community hospital and a university hospital: adverse quality of life, excess length of stay, and extra cost. Infect Control Hosp Epidemiol 2002, 23(4):183.
4. Kurtz S.M., Ong K.L., Schmier J., et al. Future clinical and economic impact of revision total hip and knee arthroplasty. J Bone Joint Surg Am 2007, 89(Suppl 3):144.
5. Senthi S., Munro J.T., Pitto R.P. Infection in total hip replacement: meta-analysis. Int Orthop 2011, 35(2):253.
6. Parvizi J., Zmistowski B., Adeli B. Periprosthetic joint infection: treatment options. Orthopedics 2010, 33(9):659.
7. Bozic K.J., Ries M.D. The impact of infection after total hip arthroplasty on hospital and surgeon resource utilization. J Bone Joint Surg Am 2005, 87(8):1746.
8. Hebert C.K., Williams R.E., Levy R.S., et al. Cost of treating an infected total knee replacement. Clin Orthop Relat Res 1996, (331):140.
9. Kurtz S.M., Lau E., Schmier J., et al. Infection burden for hip and knee arthroplasty in the United States. J Arthroplasty 2008, 23(7):984.
10. Parvizi J., Pawasarat I.M., Azzam K.A., et al. Periprosthetic joint infection: the economic impact of methicillin-resistant infections. J Arthroplasty 2010, 25(6 Suppl):103.
11. Mangram A.J., Horan T.C., Pearson M.L., et al. Guideline for prevention of surgical site infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Control 1999, 27(2):97.
12. Kurtz S., Ong K., Lau E., et al. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am 2007, 89(4):780.